Peritoneal Metastatic Gastric Cancer: Local Treatment Options and Recommendations.

Peritoneal metastasis is a common finding in patients with advanced gastric cancer. Beyond systemic chemotherapy, additive local treatments such as cytoreductive surgery and intraperitoneal chemotherapy are considered an inherent part of different multimodal treatment concepts for selected patients...

Descripción completa

Detalles Bibliográficos
Publicado en:Current Oncology Vol. 31; no. 3; pp. 1445 - 1460
Autores principales: Acs, Miklos, Piso, Pompiliu, Glockzin, Gabriel
Formato: Journal Article
Publicado: MDPI Mar2024
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=176303322&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 176303322
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        11980052
        5EKK
      jtl: Current Oncology
      issn: 11980052
      maglogo: N
    pubinfo:
      dt: Mar2024
      vid: 31
      iid: 3
      pid: 97109
      pub: MDPI
    artinfo:
      ui:
        176303322
        10.3390/curroncol31030109
        176303322
      ppf: 1445
      ppct: 15
      formats:
        fmt:
          – @attributes:
              type: T
          – @attributes:
              type: P
      tig:
        atl: Peritoneal Metastatic Gastric Cancer: Local Treatment Options and Recommendations.
      aug:
        au:
          Acs, Miklos
          Piso, Pompiliu
          Glockzin, Gabriel
        affil: Department of Surgery, University Medical Center Regensburg, 93053 Regensburg, Germany
      sug:
      ab: Peritoneal metastasis is a common finding in patients with advanced gastric cancer. Beyond systemic chemotherapy, additive local treatments such as cytoreductive surgery and intraperitoneal chemotherapy are considered an inherent part of different multimodal treatment concepts for selected patients with peritoneal metastatic gastric cancer. This review article discusses the role of cytoreductive surgery (CRS) and intraperitoneal chemotherapy, including HIPEC, NIPS, and PIPAC, as additive therapeutic options with curative and palliative intent.
      pubtype: Academic Journal
      doctype: Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N